Skip to main navigation Skip to search Skip to main content

Efficacy and Safety of Leriglitazone in Patients with Friedreich Ataxia: A Phase 2 Double-Blind, Randomized Controlled Trial (FRAMES)

  • Massimo Pandolfo
  • , Kathrin Reetz
  • , Alejandra Darling
  • , Francisco Javier Rodriguez De Rivera
  • , Pierre Gilles Henry
  • , James Joers
  • , Christophe Lenglet
  • , Isaac Adanyeguh
  • , Dinesh Deelchand
  • , Fanny Mochel
  • , Françoise Pousset
  • , Sílvia Pascual
  • , Delphine Van Den Eede
  • , Itziar Martin-Ugarte
  • , Anna Vilà-Brau
  • , Adriana Mantilla
  • , María Pascual
  • , Marc Martinell
  • , Uwe Meya
  • , Alexandra Durr

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Efficacy and Safety of Leriglitazone in Patients with Friedreich Ataxia: A Phase 2 Double-Blind, Randomized Controlled Trial (FRAMES)'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science